These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 3434491)

  • 1. [Outcome of patients in metastatic renal cell carcinoma with or without embolization].
    Masuda F; Nakada J; Takasaka S; Hishinuma H
    Hinyokika Kiyo; 1987 Sep; 33(9):1354-6. PubMed ID: 3434491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
    Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
    J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term results of endovascular treatment of metastatic renal cell cancer].
    Granov AM; Gorelov AI; Shumskiĭ IA; Polikarpov AA; Shkol'nik MI; Vorob'ev MI; Karelin MI
    Vestn Rentgenol Radiol; 1999; (6):20-3. PubMed ID: 10714226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does radical nephrectomy with immunochemotherapy have any superiority over embolization alone in metastatic renal cell carcinoma? A preliminary report.
    Demirci D; Tatlişen A; Ekmekçioğlu O; Ozcan N; Kaya R
    Urol Int; 2004; 73(1):54-8. PubMed ID: 15263794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
    Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
    J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative renal tumor embolization. A useful procedure?
    Fischedick AR; Peters PE; Kleinhans G; Pfeifer E
    Acta Radiol; 1987; 28(3):303-6. PubMed ID: 2958037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of preoperative embolization in renal cell carcinoma].
    Masuda F; Nakada J; Takasaka S; Hishinuma H; Machida T
    Gan No Rinsho; 1985 Mar; 31(3):289-92. PubMed ID: 3999392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A clinical study of renal cell carcinoma].
    Uchida T; Izumi H; Kobayashi K; Arakawa T; Honda N; Omata T; Odajima K; Mashimo S; Endo T; Ishibashi A
    Hinyokika Kiyo; 1985 Nov; 31(11):1919-25. PubMed ID: 4091134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of kidney occlusion on survival in renal cell carcinoma: a 10-year retrospective study].
    Latal D; Kautzky W; Wanek R; Kumpan W
    Z Urol Nephrol; 1990 Jan; 83(1):27-31. PubMed ID: 2330762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Embolization for renal carcinoma].
    Li S; Dong Z; Li J
    Zhonghua Wai Ke Za Zhi; 1998 Feb; 36(2):101-2. PubMed ID: 11715549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Results of endovascular interventions (embolization and chemoembolization) in the treatment of operable and extensive kidney cancer].
    Granov AM; Gorelov AI; Gershanovich ML; Karelin MI; Vorob'ev AV; Filov VA; Stukov AN
    Vopr Onkol; 1998; 44(6):711-4. PubMed ID: 10087971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and the role of nephrectomy in metastatic renal cell carcinoma.
    Uygur MC; Usubütün A; Ozen H; Ayhan A; Kendi S
    J Exp Clin Cancer Res; 1999 Sep; 18(3):397-401. PubMed ID: 10606187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No role of adjuvant systemic therapy after complete metastasectomy in metastatic renal cell carcinoma?
    Kwak C; Park YH; Jeong CW; Lee SE; Ku JH
    Urol Oncol; 2007; 25(4):310-6. PubMed ID: 17628297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival.
    Bruno JJ; Snyder ME; Motzer RJ; Russo P
    BJU Int; 2006 May; 97(5):933-8. PubMed ID: 16643473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Status of surgery in the treatment of metastatic renal cell carcinoma].
    Flamm J; Wöber L
    Wien Klin Wochenschr; 1987 Dec; 99(24):838-42. PubMed ID: 2449767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma.
    Belldegrun A; Shvarts O; Figlin RA
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S88-92. PubMed ID: 10685666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement in the prognosis of renal cell carcinoma by percutaneous transvascular embolization].
    Stösslein F; Schwenke A; Münster W; Köhler H; Mebel M; Raatzsch H; Steude U; Krosegk G
    Z Urol Nephrol; 1987 Oct; 80(10):577-86. PubMed ID: 3433986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.
    Figlin R; Gitlitz B; Franklin J; Dorey F; Moldawer N; Rausch J; deKernion J; Belldegrun A
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S92-7. PubMed ID: 9457402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relative value of adjuvant nephrectomy in metastatic renal cell carcinoma].
    Slisów W; Marx G
    Arch Geschwulstforsch; 1984; 54(6):483-90. PubMed ID: 6084496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.